Coefficient . | Estimate ± SE . | T-value . | P-value . |
---|---|---|---|
Temporal meta-region of interest | |||
APOE ε4 status | −0.0027 ± 0.0085 | −0.315 | 0.753 |
Amyloid-β status | 0.0298 ± 0.0107 | 2.785 | 0.006** |
Age | −0.0012 ± 0.0005 | −2.494 | 0.013* |
Sex | 0.0220 ± 0.0077 | 2.855 | 0.005** |
Baseline tau | 0.0577 ± 0.0151 | 3.827 | <0.001*** |
Study Avid 05 | 0.015 ± 0.010 | 1.472 | 0.141 |
Study Exp 3 | 0.008 ± 0.017 | 0.465 | 0.642 |
Study BF | 0.020 ± 0.013 | 1.551 | 0.122 |
CU | 0.009 ± 0.017 | 0.530 | 0.596 |
MCI | 0.016 ± 0.016 | 1.011 | 0.312 |
Neocortical region of interest | |||
APOE ε4 status | −0.0025 ± 0.0062 | −0.398 | 0.691 |
Amyloid-β status | 0.0145 ± 0.0062 | 1.865 | 0.062 |
Age | −0.0005 ± 0.0004 | −1.501 | 0.134 |
Sex | 0.0164 ± 0.0057 | 2.903 | 0.004** |
Baseline tau | 0.0801 ± 0.0160 | 5.014 | <0.001*** |
Study Avid 05 | 0.012 ± 0.008 | 1.604 | 0.109 |
Study Exp 3 | 0.009 ± 0.013 | 0.727 | 0.468 |
Study BF | 0.015 ± 0.010 | 1.549 | 0.122 |
CU | −0.003 ± 0.012 | −0.259 | 0.796 |
MCI | 0.001 ± 0.011 | 0.073 | 0.942 |
Coefficient . | Estimate ± SE . | T-value . | P-value . |
---|---|---|---|
Temporal meta-region of interest | |||
APOE ε4 status | −0.0027 ± 0.0085 | −0.315 | 0.753 |
Amyloid-β status | 0.0298 ± 0.0107 | 2.785 | 0.006** |
Age | −0.0012 ± 0.0005 | −2.494 | 0.013* |
Sex | 0.0220 ± 0.0077 | 2.855 | 0.005** |
Baseline tau | 0.0577 ± 0.0151 | 3.827 | <0.001*** |
Study Avid 05 | 0.015 ± 0.010 | 1.472 | 0.141 |
Study Exp 3 | 0.008 ± 0.017 | 0.465 | 0.642 |
Study BF | 0.020 ± 0.013 | 1.551 | 0.122 |
CU | 0.009 ± 0.017 | 0.530 | 0.596 |
MCI | 0.016 ± 0.016 | 1.011 | 0.312 |
Neocortical region of interest | |||
APOE ε4 status | −0.0025 ± 0.0062 | −0.398 | 0.691 |
Amyloid-β status | 0.0145 ± 0.0062 | 1.865 | 0.062 |
Age | −0.0005 ± 0.0004 | −1.501 | 0.134 |
Sex | 0.0164 ± 0.0057 | 2.903 | 0.004** |
Baseline tau | 0.0801 ± 0.0160 | 5.014 | <0.001*** |
Study Avid 05 | 0.012 ± 0.008 | 1.604 | 0.109 |
Study Exp 3 | 0.009 ± 0.013 | 0.727 | 0.468 |
Study BF | 0.015 ± 0.010 | 1.549 | 0.122 |
CU | −0.003 ± 0.012 | −0.259 | 0.796 |
MCI | 0.001 ± 0.011 | 0.073 | 0.942 |
Linear models were analysed for each region using the slopes of tau accumulation. Statistical model: Tau slopes ∼ APOE ε4 status + amyloid-β status + age + sex + study + diagnosis + baseline tau SUVR. CU = cognitively unimpaired; SE = standard error. Values in bold represent statistically significant effects.
P < 0.05;
P < 0.01;
P < 0.001.
Coefficient . | Estimate ± SE . | T-value . | P-value . |
---|---|---|---|
Temporal meta-region of interest | |||
APOE ε4 status | −0.0027 ± 0.0085 | −0.315 | 0.753 |
Amyloid-β status | 0.0298 ± 0.0107 | 2.785 | 0.006** |
Age | −0.0012 ± 0.0005 | −2.494 | 0.013* |
Sex | 0.0220 ± 0.0077 | 2.855 | 0.005** |
Baseline tau | 0.0577 ± 0.0151 | 3.827 | <0.001*** |
Study Avid 05 | 0.015 ± 0.010 | 1.472 | 0.141 |
Study Exp 3 | 0.008 ± 0.017 | 0.465 | 0.642 |
Study BF | 0.020 ± 0.013 | 1.551 | 0.122 |
CU | 0.009 ± 0.017 | 0.530 | 0.596 |
MCI | 0.016 ± 0.016 | 1.011 | 0.312 |
Neocortical region of interest | |||
APOE ε4 status | −0.0025 ± 0.0062 | −0.398 | 0.691 |
Amyloid-β status | 0.0145 ± 0.0062 | 1.865 | 0.062 |
Age | −0.0005 ± 0.0004 | −1.501 | 0.134 |
Sex | 0.0164 ± 0.0057 | 2.903 | 0.004** |
Baseline tau | 0.0801 ± 0.0160 | 5.014 | <0.001*** |
Study Avid 05 | 0.012 ± 0.008 | 1.604 | 0.109 |
Study Exp 3 | 0.009 ± 0.013 | 0.727 | 0.468 |
Study BF | 0.015 ± 0.010 | 1.549 | 0.122 |
CU | −0.003 ± 0.012 | −0.259 | 0.796 |
MCI | 0.001 ± 0.011 | 0.073 | 0.942 |
Coefficient . | Estimate ± SE . | T-value . | P-value . |
---|---|---|---|
Temporal meta-region of interest | |||
APOE ε4 status | −0.0027 ± 0.0085 | −0.315 | 0.753 |
Amyloid-β status | 0.0298 ± 0.0107 | 2.785 | 0.006** |
Age | −0.0012 ± 0.0005 | −2.494 | 0.013* |
Sex | 0.0220 ± 0.0077 | 2.855 | 0.005** |
Baseline tau | 0.0577 ± 0.0151 | 3.827 | <0.001*** |
Study Avid 05 | 0.015 ± 0.010 | 1.472 | 0.141 |
Study Exp 3 | 0.008 ± 0.017 | 0.465 | 0.642 |
Study BF | 0.020 ± 0.013 | 1.551 | 0.122 |
CU | 0.009 ± 0.017 | 0.530 | 0.596 |
MCI | 0.016 ± 0.016 | 1.011 | 0.312 |
Neocortical region of interest | |||
APOE ε4 status | −0.0025 ± 0.0062 | −0.398 | 0.691 |
Amyloid-β status | 0.0145 ± 0.0062 | 1.865 | 0.062 |
Age | −0.0005 ± 0.0004 | −1.501 | 0.134 |
Sex | 0.0164 ± 0.0057 | 2.903 | 0.004** |
Baseline tau | 0.0801 ± 0.0160 | 5.014 | <0.001*** |
Study Avid 05 | 0.012 ± 0.008 | 1.604 | 0.109 |
Study Exp 3 | 0.009 ± 0.013 | 0.727 | 0.468 |
Study BF | 0.015 ± 0.010 | 1.549 | 0.122 |
CU | −0.003 ± 0.012 | −0.259 | 0.796 |
MCI | 0.001 ± 0.011 | 0.073 | 0.942 |
Linear models were analysed for each region using the slopes of tau accumulation. Statistical model: Tau slopes ∼ APOE ε4 status + amyloid-β status + age + sex + study + diagnosis + baseline tau SUVR. CU = cognitively unimpaired; SE = standard error. Values in bold represent statistically significant effects.
P < 0.05;
P < 0.01;
P < 0.001.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.